Market Overview:
The global motion sickness treatment market is expected to grow at a CAGR of 5.5% from 2018 to 2030. The growth in the market can be attributed to the increasing prevalence of motion sickness, rising awareness about available treatments, and technological advancements in the field of motion sickness treatment. The global motion sickness treatment market is segmented on the basis of type, application, and region. On the basis of type, the market is segmented into anticholinergic drugs, antihistamines drugs, and others. Anticholinergic drugs are further sub-segmented into scopolamine hydrobromide tablets/ patches and hyoscine butylbromide tablets/ patches. Antihistamines are further sub-segmented into dimenhydrinate (Dramamine), meclizine (Antivert), cinnarizine (Stugeron), and promethazine (Phenergan). Others include gingerols capsules/ lozenges/ tea bags etc., which are used for prevention or relief from symptoms associated with Motion Sickness such as nausea or vomiting without affecting vestibular function adversely. On the basis of application, hospitals accounted for majority share in 2017 owing to availability of advanced diagnostic tests & treatments along with reimbursement policies favoring hospital admissions over clinic visits for patients suffering from Motion Sickness across developed countries such as U.S., Canada & Europe .
Product Definition:
Motion sickness is a condition that can affect people who are traveling in cars, boats, or planes. It is caused by the body's response to motion. Motion sickness treatment may include medications or other treatments.
Anticholinergic:
Anticholinergic is a type of drug that prevents the release of certain chemicals in the brain that cause nausea and vomiting. Some anticholinergic drugs are also used to treat bladder control problems, overactive bladders, and urinary incontinence. Anticholinergics are not recommended for people with untreated severe heart conditions or who have recently had a heart attack as it may increase their risk of getting chest pain or cardiac arrest.
Antihistamines:
Antihistamines are drugs that reduce the histamine response. The most common types of antihistamines are diphenhydramine (Benadryl), chlorpromazine (Thorazine), and hydroxyzine (Vaseline). They work by blocking the action of histamine, a chemical that causes itching, swelling, and pain in human skin cells.
Application Insights:
The market is segmented into hospitals, clinics, and others. The hospitals segment dominated the market in 2017 owing to factors such as government initiatives for improving healthcare infrastructure and increasing spending on medical devices & equipment. For instance, according to WHO data published in 2018, there are approximately 1 billion people who suffer from motion sickness every year globally which accounts for around 9% of the total population. Furthermore, according to a study published by NCBI in 2019 regarding motion sickness treatment options available worldwide; antihistamines were the most commonly used drugs followed by antidepressants. These factors indicate that antihistamines are widely used as first line of defense against motion sicknessness across various settings including hospitals and clinics thereby contributing towards hospital-based segment growth during the forecast period.
Regional Analysis:
North America dominated the global motion sickness treatment market in 2017. The region is expected to maintain its position during the forecast period as well. This can be attributed to increasing awareness about various treatments for motion sickness, high disposable income of consumers and improved healthcare facilities in this region. Moreover, higher adoption of preventive measures such as using anti-nausea medication before traveling will also help boost demand for these products over the forecast period.
Asia Pacific is anticipated to witness lucrative growth over the next eight years owing to factors such as improving healthcare infrastructure and rising consumer disposable income levels in developing countries like India and China which are majorly driven by rapid urbanization resulting into increased travel & tourism activities across this region thus boosting product sales at hotels, resorts & restaurants along with an increase in airfares between origin and destination thereby driving demand for these products among passengers suffering from motion sickness while flying or riding a train or bus etc., hence propelling market growth over the projected time frame.
Growth Factors:
- Increasing awareness about motion sickness and its treatment options among people.
- Growing number of research and development activities for the development of new drugs and therapies for motion sickness treatment.
- Rising demand for effective and safe medications to treat motion sickness across the globe.
- Increasing number of people travelling by air, sea, or road, which leads to an increase in the incidence of motion sickness cases worldwide.
Scope Of The Report
Report Attributes
Report Details
Report Title
Motion Sickness Treatment Market Research Report
By Type
Anticholinergic, Antihistamines, Others
By Application
Hospitals, Clinics, Others
By Companies
GlaxoSmithKline, Perrigo Company, Prestige Brands, WellSpring Pharmaceutical Corporation, Caleb Pharmaceuticals, Myungmoon Pharm, Baxter International, Reliefband Technologies
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
160
Number of Tables & Figures
112
Customization Available
Yes, the report can be customized as per your need.
Global Motion Sickness Treatment Market Report Segments:
The global Motion Sickness Treatment market is segmented on the basis of:
Types
Anticholinergic, Antihistamines, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Clinics, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- GlaxoSmithKline
- Perrigo Company
- Prestige Brands
- WellSpring Pharmaceutical Corporation
- Caleb Pharmaceuticals
- Myungmoon Pharm
- Baxter International
- Reliefband Technologies
Highlights of The Motion Sickness Treatment Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Anticholinergic
- Antihistamines
- Others
- By Application:
- Hospitals
- Clinics
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Motion Sickness Treatment Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Motion sickness treatment generally includes medications, rest, and often a trip to the doctor. Some people may also need to avoid certain types of motion or travel for a while after their symptoms subside.
Some of the major companies in the motion sickness treatment market are GlaxoSmithKline, Perrigo Company, Prestige Brands, WellSpring Pharmaceutical Corporation, Caleb Pharmaceuticals, Myungmoon Pharm, Baxter International, Reliefband Technologies.
The motion sickness treatment market is expected to register a CAGR of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Motion Sickness Treatment Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Motion Sickness Treatment Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Motion Sickness Treatment Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Motion Sickness Treatment Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Motion Sickness Treatment Market Size & Forecast, 2020-2028
4.5.1 Motion Sickness Treatment Market Size and Y-o-Y Growth
4.5.2 Motion Sickness Treatment Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Anticholinergic
5.2.2 Antihistamines
5.2.3 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Hospitals
6.2.2 Clinics
6.2.3 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Motion Sickness Treatment Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Motion Sickness Treatment Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Anticholinergic
9.6.2 Antihistamines
9.6.3 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Hospitals
9.10.2 Clinics
9.10.3 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Anticholinergic
10.6.2 Antihistamines
10.6.3 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Hospitals
10.10.2 Clinics
10.10.3 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Anticholinergic
11.6.2 Antihistamines
11.6.3 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Hospitals
11.10.2 Clinics
11.10.3 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Anticholinergic
12.6.2 Antihistamines
12.6.3 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Hospitals
12.10.2 Clinics
12.10.3 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Anticholinergic
13.6.2 Antihistamines
13.6.3 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Hospitals
13.10.2 Clinics
13.10.3 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Motion Sickness Treatment Market: Competitive Dashboard
14.2 Global Motion Sickness Treatment Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 GlaxoSmithKline
14.3.2 Perrigo Company
14.3.3 Prestige Brands
14.3.4 WellSpring Pharmaceutical Corporation
14.3.5 Caleb Pharmaceuticals
14.3.6 Myungmoon Pharm
14.3.7 Baxter International
14.3.8 Reliefband Technologies
